These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 17186855)
1. Response of canine cutaneous epitheliotropic lymphoma to lomustine (CCNU): a retrospective study of 46 cases (1999-2004). Risbon RE; de Lorimier LP; Skorupski K; Burgess KE; Bergman PJ; Carreras J; Hahn K; Leblanc A; Turek M; Impellizeri J; Fred R; Wojcieszyn JW; Drobatz K; Clifford CA J Vet Intern Med; 2006; 20(6):1389-97. PubMed ID: 17186855 [TBL] [Abstract][Full Text] [Related]
2. CCNU in the treatment of canine epitheliotropic lymphoma. Williams LE; Rassnick KM; Power HT; Lana SE; Morrison-Collister KE; Hansen K; Johnson JL J Vet Intern Med; 2006; 20(1):136-43. PubMed ID: 16496933 [TBL] [Abstract][Full Text] [Related]
3. Treatment of canine mast cell tumors with CCNU (lomustine). Rassnick KM; Moore AS; Williams LE; London CA; Kintzer PP; Engler SJ; Cotter SM J Vet Intern Med; 1999; 13(6):601-5. PubMed ID: 10587263 [TBL] [Abstract][Full Text] [Related]
4. Is CCNU (lomustine) valuable for treatment of cutaneous epitheliotropic lymphoma in dogs? A critically appraised topic. Laprais A; Olivry T BMC Vet Res; 2017 Feb; 13(1):61. PubMed ID: 28222789 [TBL] [Abstract][Full Text] [Related]
5. Lomustine (CCNU) for the treatment of resistant lymphoma in dogs. Moore AS; London CA; Wood CA; Williams LE; Cotter SM; L'Heureux DA; Frimberger AE J Vet Intern Med; 1999; 13(5):395-8. PubMed ID: 10499719 [TBL] [Abstract][Full Text] [Related]
12. Tolerability of metronomic administration of lomustine in dogs with cancer. Tripp CD; Fidel J; Anderson CL; Patrick M; Pratt C; Sellon R; Bryan JN J Vet Intern Med; 2011; 25(2):278-84. PubMed ID: 21314727 [TBL] [Abstract][Full Text] [Related]
13. Canine cutaneous lymphoma. McKeever PJ; Grindem CB; Stevens JB; Osborne CA J Am Vet Med Assoc; 1982 Mar; 180(5):531-6. PubMed ID: 7061338 [TBL] [Abstract][Full Text] [Related]
14. Lomustine for treatment of mast cell tumors in cats: 38 cases (1999-2005). Rassnick KM; Williams LE; Kristal O; Al-Sarraf R; Baez JL; Zwahlen CH; Dank G J Am Vet Med Assoc; 2008 Apr; 232(8):1200-5. PubMed ID: 18412534 [TBL] [Abstract][Full Text] [Related]
15. Hepatotoxicity associated with CCNU (lomustine) chemotherapy in dogs. Kristal O; Rassnick KM; Gliatto JM; Northrup NC; Chretin JD; Morrison-Collister K; Cotter SM; Moore AS J Vet Intern Med; 2004; 18(1):75-80. PubMed ID: 14765735 [TBL] [Abstract][Full Text] [Related]
16. Updates on the management of canine epitheliotropic cutaneous T-cell lymphoma. de Lorimier LP Vet Clin North Am Small Anim Pract; 2006 Jan; 36(1):213-28, viii-ix. PubMed ID: 16364786 [No Abstract] [Full Text] [Related]
17. CD3 and CD20 Coexpression in a Case of Canine Cutaneous Epitheliotropic T-Cell Lymphoma (Mycosis Fungoides). Brachelente C; Affolter VK; Fondati A; Porcellato I; Sforna M; Lepri E; Mechelli L; Bongiovanni L Vet Pathol; 2016 May; 53(3):563-6. PubMed ID: 26354309 [TBL] [Abstract][Full Text] [Related]
18. Lomustine and prednisone as a first-line treatment for dogs with multicentric lymphoma: 17 cases (2004-2005). Sauerbrey ML; Mullins MN; Bannink EO; Van Dorp TE; Kaneene JB; Obradovich JE J Am Vet Med Assoc; 2007 Jun; 230(12):1866-9. PubMed ID: 17571992 [TBL] [Abstract][Full Text] [Related]
19. Epitheliotropic lymphoma (mycosis fungoides) presenting as blepharoconjunctivitis in an Irish setter. Donaldson D; Day MJ J Small Anim Pract; 2000 Jul; 41(7):317-20. PubMed ID: 10976628 [TBL] [Abstract][Full Text] [Related]
20. A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumours. Rassnick KM; Bailey DB; Russell DS; Flory AB; Kiselow MA; Intile JL; Malone EK; Balkman CE; Barnard SM Vet Comp Oncol; 2010 Jun; 8(2):138-52. PubMed ID: 20579327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]